The Metallium Ltd (ASX: MTM) share price is in focus as the company reported the resumption of chlorinated testing at its Texas Technology Campus and confirmed its first revenue from the ECT MXene program.
What did Metallium report?
- Chlorinated Flash Joule Heating (FJH) testing to recommence this week at Gator Point, Texas
- First revenue under the ECT MXene testing agreement: US$500,000 payment underway, full receipt expected by week’s end
- Continued build-out at Gator Point, with Area 140 roof restoration due to finish in early September
- Expansion of on-site laboratory capabilities for advanced materials testing and FJH optimisation
- John Campo appointed as Texas-based Head of Engineering, adding 30 years’ industry experience
What else do investors need to know?
Metallium resolved a site and permitting issue at its Gator Point campus by securing additional land from Chambers County for nominal consideration. This has enabled the recommencement of testing and further expanded Metallium’s relationship with the local community and authorities.
The company has upgraded safety systems, operating procedures, and emergency readiness to support chlorinated testing. It has also invested in new analytical equipment for its laboratory, such as X-ray diffraction and thermogravimetric analysis, to accelerate testing and optimisation.
Preparations are advanced for the ECT MXene campaign, focusing on the application of Metallium’s FJH technology for innovative two-dimensional materials used in electronics, defence, and energy storage.
What did Metallium management say?
Managing Director & CEO Michael Walshe said:
With the site constraint now resolved, we can recommence chlorinated testing and continue progressing the FJH platform toward commercialisation. Our immediate focus is the planned 12-hour multi-reactor campaign in September
I would particularly like to thank Chambers County and the Chambers County Landfill for working constructively with us to reach a practical solution. Their support has been greatly appreciated and reflects the strong relationship we are continuing to build with the local community.
We are also continuing to expand the capability at Gator Point. The Area 140 roof is nearing completion, we are adding further analytical capability to our on-site laboratory, and preparations are underway for the ECT MXene testing campaign. The first US$500,000 ECT payment is also underway, with full receipt expected by the end of this week. John Campo’s appointment as Head of Engineering further strengthens the team as we continue to develop and scale the FJH platform.
What’s next for Metallium?
Looking forward, Metallium aims to complete key infrastructure at its Texas campus and push ahead with its multi-reactor campaign in September. The MXene testing program is expected to provide new commercial opportunities as advanced materials markets expand.
With a strengthened technical team and growing laboratory capabilities, the company’s focus remains on scaling up its proprietary FJH technology for critical and precious metals recovery, aligning with the demand for supply chain security and sustainability.
Metallium share price snapshot
Over the past 12 months, Metallium shares have declined 43%, significantly trailing the All Ordinaries Index (ASX: XAO)
The post Metallium resumes testing and records first commercial revenue appeared first on The Motley Fool Australia.
Should you invest $1,000 in Metallium Ltd right now?
Before you buy Metallium Ltd shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Metallium Ltd wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 August 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.